Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
University of California, San Francisco
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins